Drug points: Weight loss associated with levetiracetam

18 October 2003

journal article
case report
Published by BMJ in BMJ

Vol. 327 (7420) , 905
https://doi.org/10.1136/bmj.327.7420.905

Abstract

Footnotes Funding None. Competing interests PS has received an unrestricted research grant from UCB Pharma, manufacturer of levetiracetam, and has received payments for speaking and hospitality from UCB Pharma, GlaxoSmithKline, and Novartis. TP and SH have received unrestricted educational grants from GlaxoSmithKline, manufacturer of lamotrigine.

Keywords

RESEARCH GRANT
EDUCATIONAL GRANTS
FOOTNOTES FUNDING
INTERESTS PS
LEVETIRACETAM FOOTNOTES
COMPETING INTERESTS
UCB PHARMA
UNRESTRICTED EDUCATIONAL
DRUG POINTS

This publication has 2 references indexed in Scilit: